Sentence examples for harmful medicines from inspiring English sources

Re "The Public's Quiet Savior From Harmful Medicines" (Sept . 14: Dr. Francis Oldham Kelsey deserves every encomium she has received for her uncompromising actions in the thalidomide scandal.

Patients risked receiving ineffective and potentially harmful medicines by being misled into believing they were taking a drug tailored to their condition, the chief executive of the Consumers Health Forum, Adam Stankevicius, said.

Research shows many doctors spend almost no time examining their patients, commonly miss diagnoses, and often prescribe useless or harmful medicines.

These are the citizen champions who, for example, led the fight for safer and nutritious food, less harmful medicines, cleaner air and water, more secure pensions, a freer media, more open government, waging peace instead of war, securing indigenous peoples' rights, safer transportation, the well-being of children, insurance industry accountability and great advances for people with disabilities.

Some practices are reluctant to include potentially harmful medicines that need frequent monitoring (such as methotrexate) on the repeat template.

Allowing the regular administration of potentially harmful medicines to go virtually unchecked sets a dangerous precedent, irrespective of the assumed clinical benefit.

Furthermore, the related investigation on response mechanism will be helpful to design and synthesize new metal nanoclusters as fluorescent probe to detect the trace amount of harmful medicine residuum as nitroimidazoles in human body.

Meanwhile, more than two-thirds got unnecessary or harmful medicine, according to a report published in June by the World Bank.

The BMQ-General evaluates general medication beliefs and comprises two 4-item factors: General-Harm (medicines are harmful, addictive or poisonous) and General-Overuse (medicines are overused or excessively trusted by doctors).

While it is important to improve systems that protect patients from harmful fake medicines — both patented and generic — the problem in many countries is not the need for more laws, but the need for improved enforcement of already existing laws and more resources for drug regulatory authorities.

The precision and timeliness in reporting suspected product inadequacy must improve in order for the global pharmacovigilance system to be of broader value in the detection of harmful substandard medicines.